Chemotherapeutic Regimens
From WikiLectures
Chemotherapeutic Regimen is usually a well-established combination of chemotherapeutics used to treat cancer. Medical reports often only provide abbreviations for each regimen. In the following table you will find the abbreviation, the drugs contained and the possible indication.
This page does not serve as a guide for the indication of chemotherapeutic regimens!
| Abbreviation | Medicines | Possible Indication |
|---|---|---|
| ABVD | Adriamycin, Bleomycin, Vinblastine, Dacarbazine | Hodgkin's lymphoma |
| AC | Adriamycin, Cyclophosphamide | Breast cancer |
| BEACOPP | Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Oncovin (Vincristine), Prednisone, Procarbazine | Hodgkin's lymphoma |
| CMF | Cyclophosphamide, Methotrexate, Fluoruracil | Breast cancer |
| COP | Cyclophosphamide, Oncovin (Vincristine), Prednisone | Folicular Lymphoma |
| CHOP | Cyclophosphamide, Adriamycin, Oncovin (Vincristine), Prednisone | Folicular Lymphoma |
| CVD | Cyclophosphamide, Dacarbazine, Vincristine | Pheochromocytoma, Plasmacytoma |
| EC | Epirubicin, Cyclophosphamide | Breast cancer |
| EP | Etoposide, Cisplatine | |
| FAC | Fluoruracil, Adriamycin, Cyclophosphamide | Breast cancer |
| FAM | Fluoruracil, Adriamycin, Mitomycin C | |
| FEC | Floruracil, Epirubicin, Cyclophosphamide | Breast cancer |
| FUFA | Fluoruracil, Leucovorin | |
| GC | Gentamycin, Cisplatin | |
| MVAC | Methotrexate, Vinblastin, Adriamycin, Cisplatin | |
| VAD | Vincristin, Adriamycin, Dexamethasone | Plasmacytoma |
References[edit | edit source]
Related Articles[edit | edit source]
References Used[edit | edit source]
- {{#switch: kniha
|book =
Incomplete publication citation. . Special Oncology. 978-80-7262-438-6.
|collection =
Incomplete citation of contribution in proceedings. . Special Oncology. {{
#if: 9788073455392 |978-80-7262-438-6} }
|article =
Incomplete article citation. .
|web =
Incomplete site citation. .
|cd =
Incomplete carrier citation. .
|db =
Incomplete database citation.
|corporate_literature =
Incomplete citation of company literature. . Special Oncology. 978-80-7262-438-6} }
